Life Science Today
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs.
Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
DICE, Odyssey, Fred Hutch, Merck (MSD)
One biotech is on a roll, another is moving quickly, Amazon money for cancer, and some clinical development news
Find out more at
https://LifeScienceTodayPodcast.com
Story References
DICE
Odyssey
Fred Hutch
Merck (MSD), Merck Story 2
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Nested, Cellarity, Replimune, Estralla
Biotech’s with a series A, a series C, some debt financing, and there is even a Biopharma heading for a SPAC
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Nested Therapeutics
Cellarity
Replimune
Estralla Biopharma
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Eisai + Biogen, Amylyx, Sanofi + Regeneron
Major Alzheimer’s news, an ALS approval, and expanded therapies for skin conditions
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Eisai + Biogen
Amylyx
Sanofi + Regeneron
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Alnylam, Intellia, Third Harmonic, Galvanize
A $900 raise, gene therapy news, a quick IPO, and merge three for $100M
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Alnylam, Link 2, Link 3
Intellia Therapeutics
Third Harmonic Bio
Galvanize Therapeutics
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Revance, Velocity + MedPharmics, Arsenal, SpringWorks
A critical aesthetics approval, site network buy-up, a very normal oncology biotech, and a busy week for one company.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Revance
Velocity + MedPharmics
Arsenal
SpringWorks Link 1, Link 2, Link 3
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Novo + Forma, Sanofi, Boehringer Ingelheim, Arcturus
A $1.1B acquisition, two FDA approvals, and grants for mRNA vaccines.
Find out more at
https://LifeScienceTodayPodcast.com
Story References
Novo + Forma
Sanofi
Boehringer Ingelheim
Arcturus
About the Show
Life Science Today is your source for stories, insights, and trends across the life science industry. Expect weekly highlights about new technologies, pharmaceutical mergers and acquisitions, news about the moves of venture capital and private equity, and how the stock market responds to biotech IPOs. Life Science Today also explores trends around clinical research, including the evolving patterns that determine how drugs and therapies are developed and approved. It’s news, with a dash of perspective, focused on the life science industry.
Responses